Cyclic disulfonic ester cross-linking compounds

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

556428, C07D33900

Patent

active

049507680

ABSTRACT:
Cyclic disulfonic ester bifunctional cross-linking compounds effective in treating certain types of cancers are described. Initial nucleophilic reaction with the compound produces a negatively charged sulfonic acid end-group which remains attached to the compound until the second nucleophilic crosslinking reaction occurs.

REFERENCES:
patent: 4483799 (1984-11-01), Kampfer et al.
Remers, W. A., "Antineoplastic Agents", John Wiley & Sons, New York, N.Y., 1984, pp. 69-76.
Hecht, A., "Cancer Drugs That Work", FDA Consumer, Oct., 1977, pp. 18, 20, 21.
Hayashi et al., Chemical and Pharmaceutical Bulletin, vol. 12, No. 11, 1964, pp. 1271-1272.
Leong, "Synthesis of Cyclic Methanedisulfonate Esters by the Silver Salt Method", Reed College Chemistry Library, 1972.
Engel, "Synthesis of Cyclic Methanedisulfonate by Diol Reaction Method", Reed College Chemistry Library, 1981.
McCaffrey, "Synthesis of Cyclic Methanedisulfonates: Analogues of Myleran-A Cancer Chemotherapy Compound", Reed College Chemistry Library, 1982.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclic disulfonic ester cross-linking compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic disulfonic ester cross-linking compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic disulfonic ester cross-linking compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1678693

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.